Chicago Partners Investment Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,431
| Closed | -$440K | – | 981 |
|
|
2024
Q4 | $440K | Buy |
5,431
+458
| +9% | +$37.1K | 0.01% | 543 |
|
|
2024
Q3 | $558K | Sell |
4,973
-93
| -2% | -$10.4K | 0.02% | 460 |
|
|
2024
Q2 | $405K | Sell |
5,066
-943
| -16% | -$75.3K | 0.02% | 523 |
|
|
2024
Q1 | $366K | Buy |
6,009
+132
| +2% | +$8.04K | 0.02% | 520 |
|
|
2023
Q4 | $372K | Sell |
5,877
-1,285
| -18% | -$81.2K | 0.02% | 492 |
|
|
2023
Q3 | $336K | Buy |
7,162
+1,005
| +16% | +$47.1K | 0.02% | 488 |
|
|
2023
Q2 | $309K | Sell |
6,157
-1,002
| -14% | -$50.4K | 0.02% | 523 |
|
|
2023
Q1 | $311K | Buy |
+7,159
| New | +$311K | 0.02% | 500 |
|
|
2022
Q4 | – | Sell |
-6,402
| Closed | -$278K | – | 654 |
|
|
2022
Q3 | $278K | Buy |
+6,402
| New | +$278K | 0.02% | 457 |
|
|
2021
Q1 | – | Sell |
-10,653
| Closed | -$268K | – | 529 |
|
|
2020
Q4 | $268K | Buy |
+10,653
| New | +$268K | 0.03% | 386 |
|